Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Diagnostic Equipment

Instrumentation Laboratory: ACL Elite Analyzers Recalled to Remove Specific Test Definitions

Agency Publication Date: September 30, 2024
Share:
Sign in to monitor this recall

Summary

Instrumentation Laboratory is recalling approximately 521 ACL Elite and Elite Pro analyzers in the United States (and over 3,000 units globally) to remove the test definition for HemosIL Liquid Anti-Xa (Part Numbers 0020302600 and 0020302601) from the instrument software. These instruments are used in clinical laboratories for blood coagulation and fibrinolysis testing. The removal of this specific test definition is necessary to ensure the accuracy and reliability of diagnostic results for patients requiring Anti-Xa monitoring.

Risk

The presence of the specific test definition for HemosIL Liquid Anti-Xa on these instruments may lead to incorrect test configurations or results. Incorrect results in hemostasis testing could potentially lead to improper clinical management of patients on anticoagulant therapy.

What You Should Do

  1. Check your laboratory instrument to see if it is an ACL ELITE or ACL ELITE PRO analyzer, including refurbished models.
  2. Verify the Part Number and Serial Number on your device: ACL ELITE (PN 0000880311, Serial 23012282 and prior), ACL ELITE PRO (PN 0001000311, Serial 23015246 and prior), or Refurbished models (PN 0000880311R/0001000311R).
  3. Confirm if your instrument currently contains the test definition for HemosIL Liquid Anti-Xa (Part Numbers 0020302600 or 0020302601).
  4. Contact your healthcare provider or Instrumentation Laboratory directly to receive instructions on how to remove the affected test definitions from your instrument software.
  5. For additional questions or technical support, contact the manufacturer (Instrumentation Laboratory) at their Bedford, Massachusetts location or call the FDA's medical device line at 1-888-463-6332.

Your Remedy Options

๐Ÿ“‹Other Action

Removal of test definition from instrument software.

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: ACL ELITE Analyzer
Model / REF:
0000880311
UPC Codes:
08426950453017
Lot Numbers:
Serial Numbers 23012282 and Prior
Product: ACL ELITE PRO Analyzer
Model / REF:
0001000311
UPC Codes:
08426950451570
Lot Numbers:
Serial Number 23015246 and Prior
Product: ACL ELITE Refurbished Analyzer
Model / REF:
0000880311R
UPC Codes:
08426950965572
Lot Numbers:
Serial Number 11121320R and Prior
Product: ACL ELITE PRO Refurbished Analyzer
Model / REF:
0001000311R
UPC Codes:
08426950453482
Lot Numbers:
Serial Number 16053360R and Prior

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 91748
Status: Active
Manufacturer: Instrumentation Laboratory
Sold By: Clinical hemostasis laboratories; Hospitals
Manufactured In: United States
Units Affected: 4 products (358 units US; 558 units OUS; 129 units US; 2686 units OUS; 1 unit US; 33 units OUS)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.